Skip to content
OpenCapital
Get started

Xtant Medical Holdings XTNT Cash & Equivalents

Cash & Equivalents at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$21.69B-43.6%
Stryker logo
StrykerSYK
$2.88B+24.1%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$120.28M+108%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$424.2M-69.4%
Globus Medical logo
Globus MedicalGMED
$560.95M+21.6%
Alphatec Holdings logo
Alphatec HoldingsATEC
$139.91M-8.7%

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02—

Balance sheet

See full
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-31.2%
Enterprise value$61.89M-40.4%
P/E32.3×—
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's cash & equivalents?
Xtant Medical Holdings (XTNT) reported cash & equivalents of $12.16M in Q1 2026.
How has Xtant Medical Holdings's cash & equivalents changed year-over-year?
Xtant Medical Holdings's cash & equivalents increased by 123.7% year-over-year, from $5.44M to $12.16M.
What is the long-term trend for Xtant Medical Holdings's cash & equivalents?
Over 5 years (2020 to 2025), Xtant Medical Holdings's cash & equivalents has grown at a 49.2% compound annual growth rate (CAGR), from $2.34M to $17.33M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.